4 Results for "

RBD:ACE2 interaction

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "RBD:ACE2 interaction" in MCE Product Catalog:

Cat. No.: HY-156441
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-65 (compound 2f (81)) is a potent,orally active and reversible SARS-CoV-2 entry inhibitor. SARS-CoV-2-IN-65 inhibits the pseudovirus entry in a ACE2-dependent pathway, via mainly inhibiting RBD:ACE2 interaction and TMPRSS2 activity in Calu-3 cells .
loading...
    loading...
Cat. No.: HY-169977
Target:  

SARS-CoV

Research Areas:  

Infection

CKP-25 is an inhibitor for the interaction between Spike RBD-ACE2, that prevents the virus from entering the host cell, thereby reducing the replication and virus infection. CKP-25 inhibits SARS-CoV-2 with IC50 of 3.5 μM in Vero E6 cell .
loading...
    loading...
Cat. No.: HY-162550
CAS No.: 223611-93-6
Target:  

SARS-CoV

Research Areas:  

Infection

Jobosic acid, a saturated fatty acid, is a selective SARS-CoV-2 inhibitor. Jobosic acid inhibits Mpro and spike-RBD/ACE-2 interaction with IC50 values of 7.5 μg/mL and 3 μg/mL, respectively. Jobosic acid shows viral entry inhibition for the omicron SARS-CoV-2 variant .
loading...
    loading...
Cat. No.: HY-180129
CAS No.: 308293-08-5
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-120 (Compound S22) is a SARS-CoV-2-specific entry inhibitor. SARS-CoV-2-IN-120 binds and trimerizes within the apex cavity of the SARS2 spike trimer. SARS-CoV-2-IN-120 blocks RBD-ACE2 interaction. SARS-CoV-2-IN-120 neutralizes BA.2 and subsequent Omicron variants. SARS-CoV-2-IN-120 inhibits SARS-CoV-2 replication in mice .
loading...
    loading...